Get the Stockscreener App
1.97
3.14%
0.06
After Hours:
1.95
-0.02
-1.02%
Inmune Bio Inc stock is traded at $1.97, with a volume of 325.44K.
It is up +3.14% in the last 24 hours and down -22.13% over the past month.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
See More
Previous Close:
$1.91
Open:
$1.92
24h Volume:
325.44K
Relative Volume:
0.10
Market Cap:
$52.37M
Revenue:
$155.00K
Net Income/Loss:
$-30.01M
P/E Ratio:
-1.1796
EPS:
-1.67
Net Cash Flow:
$-11.98M
1W Performance:
+0.00%
1M Performance:
-22.13%
6M Performance:
-72.60%
1Y Performance:
-62.04%
1-Day Range:
$1.92
$1.99
1-Week Range:
$1.91
$2.12
52-Week Range:
$1.71
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
Name
Inmune Bio Inc
Sector
Industry
Phone
(858) 964-3720
Address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
Compare INMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.97 | 50.78M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-01-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-01-25 | Downgrade | Scotiabank | Sector Outperform → Sector Underperform |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Oct-21-24 | Initiated | Alliance Global Partners | Buy |
| Sep-27-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Scotiabank | Sector Outperform |
| Jun-01-23 | Initiated | Robert W. Baird | Outperform |
| May-24-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jul-07-21 | Reiterated | Maxim Group | Buy |
| Apr-21-21 | Initiated | B. Riley Securities | Buy |
| Jan-22-21 | Reiterated | Maxim Group | Buy |
| Sep-01-20 | Initiated | BTIG Research | Buy |
| Jul-15-20 | Reiterated | H.C. Wainwright | Buy |
View All
Inmune Bio Inc Stock (INMB) Latest News
Retail Surge: Is INmune Bio Inc a stock for growth or value investorsQuarterly Investment Review & AI Driven Stock Reports - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Short Interest Down 29.8% in August - MarketBeat
Aug Macro: Is INmune Bio Inc. impacted by rising rates2025 Geopolitical Influence & AI Based Trade Execution Alerts - خودرو بانک
INmune Bio, Inc. (NASDAQ:INMB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
INmune Bio, Inc. (NASDAQ:INMB) Receives $18.40 Consensus PT from Analysts - Defense World
Loss Report: Can INmune Bio Inc stock outperform in a bear marketWeekly Profit Analysis & Scalable Portfolio Growth Methods - خودرو بانک
VIX Spike: Is INmune Bio Inc stock undervalued right nowJuly 2025 Rallies & Reliable Trade Execution Plans - خودرو بانک
Meme Stocks: How is i 80 Gold Corp managing supply chain issuesEarnings Summary Report & Daily Chart Pattern Signal Reports - خودرو بانک
Aug Summary: Will INmune Bio Inc benefit from geopolitical trendsJuly 2025 EndofMonth & Capital Efficient Trade Techniques - خودرو بانک
Aug Outlook: Is INmune Bio Inc a stock for growth or value investorsJuly 2025 Chart Watch & Accurate Intraday Trade Tips - خودرو بانک
Bearish Setup: Is INmune Bio Inc stock a value trapNew Guidance & Weekly Breakout Opportunity Watchlist - خودرو بانک
Risks Report: Is INmune Bio Inc. stock a falling knife or bargain buyWeekly Investment Summary & Accurate Entry and Exit Point Alerts - خودرو بانک
Published on: 2025-09-16 12:20:17 - خودرو بانک
Aug Macro: Will INmune Bio Inc. benefit from rate cutsJuly 2025 Update & Consistent Profit Trade Alerts - خودرو بانک
Will INmune Bio Inc benefit from geopolitical trendsWeekly Loss Report & Consistent Growth Stock Picks - خودرو بانک
Aug Retail: Will INmune Bio Inc. outperform the market in YEAR2025 Support & Resistance & High Accuracy Investment Signals - خودرو بانک
INmune Bio (INMB) Completes Pilot Manufacturing of CORDStrom for Skin Disorder - GuruFocus
Aug Drivers: Can INmune Bio Inc. stock outperform in a bear marketShare Buyback & Target Return Focused Picks - خودرو بانک
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult - The Manila Times
INmune Bio Inc. Achieves Key Milestone with Successful Pilot Manufacturing Run of CORDStrom™ for RDEB Treatment - Quiver Quantitative
Breakthrough in Rare Disease Treatment: INmune Bio Successfully Manufactures RDEB Cell Therapy at UK Facility - Stock Titan
Gains Recap: What are INmune Bio Incs earnings expectations2025 Winners & Losers & Community Verified Trade Alerts - خودرو بانک
Aug Update: Can INmune Bio Inc. expand into new marketsJuly 2025 Reactions & Smart Allocation Stock Tips - خودرو بانک
How to escape a deep drawdown in INmune Bio Inc.2025 Market Outlook & Verified Momentum Stock Alerts - newser.com
Recovery Setup Building in INmune Bio Inc. Experts Say2025 Macro Impact & Real-Time Stock Price Movement Reports - beatles.ru
INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Is INmune Bio Inc. stock a value trapJuly 2025 Highlights & Weekly Breakout Watchlists - beatles.ru
INmune Bio Inc. stock trend forecastJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - Newser
Technical signs of recovery in INmune Bio Inc.Quarterly Profit Summary & High Accuracy Investment Entry Signals - Newser
What is INmune Bio Inc.’s book value per shareJuly 2025 Drop Watch & AI Based Trade Execution Alerts - خودرو بانک
Does INmune Bio Inc. have a competitive edge2025 Geopolitical Influence & Fast Moving Stock Watchlists - خودرو بانک
Is INmune Bio Inc. stock a falling knife or bargain buyJuly 2025 Closing Moves & Verified Short-Term Plans - خودرو بانک
Relative strength of INmune Bio Inc. in sector analysisTrade Risk Summary & Daily Technical Forecast Reports - Newser
What momentum shifts mean for INmune Bio Inc.Quarterly Growth Report & Low Drawdown Trading Strategies - Newser
Technical signs of recovery in INmune Bio Inc2025 Price Action Summary & Momentum Based Trading Ideas - Newser
What’s next for INmune Bio Inc. stock priceJuly 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Detecting price anomalies in INmune Bio Inc. with AIExit Point & Risk Controlled Swing Alerts - Newser
Can INmune Bio Inc. rally from current levelsPortfolio Growth Summary & Consistent Profit Focused Trading Strategies - Newser
What makes INmune Bio Inc. stock price move sharplyJuly 2025 Snapshot & Stock Portfolio Risk Control - Newser
What to do if you’re stuck in INmune Bio Inc.Stock Surge & Free High Accuracy Swing Entry Alerts - Newser
News impact scoring models applied to INmune Bio Inc.Weekly Trading Summary & Daily Growth Stock Investment Tips - Newser
Will INmune Bio Inc. outperform the market in YEARTrade Exit Report & Daily Technical Stock Forecast Reports - خودرو بانک
Evaluating INmune Bio Inc. with trendline analysisQuarterly Portfolio Report & Stepwise Trade Signal Implementation - Newser
Can swing trading help recover from INmune Bio Inc. lossesJuly 2025 Short Interest & Capital Efficiency Focused Strategies - Newser
INmune Bio Inc.’s volatility index tracking explainedGold Moves & Verified Momentum Stock Alerts - Newser
Inmune Bio Inc. shares rise 1.02% premarket after Tevogen Bio Holdings Inc. highlights the importance of SARS-CoV-2 treatments for weakened immune systems. - AInvest
Visual analytics tools that track INmune Bio Inc. performanceQuarterly Trade Review & Community Consensus Trade Alerts - Newser
Will INmune Bio Inc. be affected by tariffs2025 Trade Ideas & Entry Point Strategy Guides - خودرو بانک
Can you recover from losses in INmune Bio Inc.Treasury Yields & Advanced Swing Trade Entry Alerts - Newser
Will INmune Bio Inc. outperform tech stocksJuly 2025 Sector Moves & Stepwise Trade Signal Implementation - خودرو بانک
Backtesting results for INmune Bio Inc. trading strategiesJuly 2025 Drop Watch & Low Drawdown Trading Techniques - Newser
Inmune Bio Inc Stock (INMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):